Global Chronic Disease
Management Market Segmentation, By Disease Type (Cardiovascular Diseases, Diabetes,
Chronic Respiratory Diseases, Cancer, Chronic Kidney Disease, Neurological
Disorders, Arthritis & Musculoskeletal Disorders, Mental Health Conditions,
Other Chronic Conditions), By Component (Software & Solutions {Electronic
Health Records (EHR) Integration, Clinical Decision Support Systems, Patient
Engagement Solutions, Remote Patient Monitoring Platforms, Analytics &
Reporting Tools}, Services {Consulting & Implementation, Training &
Education, Support & Maintenance}, Hardware {Remote Monitoring Devices, Wearable
Medical Devices, Mobile Health Devices}), By Mode of Delivery (On-Premises Solutions,
Cloud-Based Solutions, Web-Based Platforms), By End User (Healthcare Providers,
Payers, Patients/Individuals, Employers & Corporate Wellness Programs, Research
Institutions), By Intervention Type (Preventive Care Management, Chronic Care
Management, Rehabilitation Services, Palliative Care), By Technology (Telehealth
& Telemedicine, mHealth (Mobile Health), Artificial Intelligence &
Machine Learning, Big Data & Analytics, IoT & Connected Devices, Blockchain
for Health Data Security)- Industry Trends and Forecast to 2033
Global Chronic Disease Management
Market size was valued at USD 6137.4 million in 2024 and is expected to reach at
USD 15937.4 million in 2033, with a CAGR of 14.2% during the forecast period of
2025 to 2033.
Global Chronic Disease Management Market Overview
The Chronic Disease Management
(CDM) marketplace specializes in enhancing affected person outcomes, decreasing
healthcare costs, and improving quality of life via long-time period tracking
and remedy solutions for conditions together as diabetes, cardiovascular
diseases, cancer, and breathing disorders. Rising incidence of chronic
illnesses, an ageing population, and the shift in the direction of
value-primarily based totally healthcare models are driving the adoption of CDM
programs. Integration of virtual fitness equipment like telemedicine, far-flung
tracking devices, and AI-powered analytics is, in addition, remodelling patient
care. Additionally, developing authorities initiatives, repayment support, and
growing collaboration amongst healthcare carriers and era agencies are fuelling
market expansion globally.
Global Chronic Disease Management Market Scope
|
Global Chronic
Disease Management Market |
|||
|
Years
Considered |
|||
|
Historical Period |
2020 - 2023 |
Market Size (2024) |
USD 6137.4 Million |
|
Base Year |
2024 |
Market Size
(2033) |
USD 15937.4 Million |
|
Forecast Period |
2025 - 2033 |
CAGR (2025 – 2033) |
14.2% |
|
Segments
Covered |
|||
|
By Disease Type |
·
Cardiovascular Diseases ·
Diabetes ·
Chronic Respiratory Diseases ·
Cancer ·
Chronic Kidney Disease ·
Neurological Disorders ·
Arthritis & Musculoskeletal Disorders ·
Mental Health Conditions ·
Other Chronic Conditions |
||
|
By Components |
·
Software
& Solutions o Electronic Health Records (EHR)
Integration o Clinical Decision Support
Systems o Patient Engagement Solutions o Remote Patient Monitoring
Platforms o Analytics & Reporting Tools ·
Services o Consulting & Implementation o Training & Education o Support & Maintenance ·
• Hardware o Remote Monitoring Devices o Wearable Medical Devices o Mobile Health Devices |
||
|
By Mode of Delivery |
·
On-Premises Solutions ·
Cloud-Based Solutions ·
Web-Based Platforms |
||
|
By End User |
·
Healthcare
Providers ·
Payers ·
Patients/Individuals ·
Employers
& Corporate Wellness Programs ·
Research
Institutions |
||
|
By Intervention Type |
·
Preventive Care Management ·
Chronic Care Management ·
Rehabilitation Services ·
Palliative Care |
||
|
By Technology |
·
Telehealth
& Telemedicine ·
mHealth
(Mobile Health) ·
Artificial
Intelligence & Machine Learning ·
Big
Data & Analytics ·
IoT
& Connected Devices ·
Blockchain
for Health Data Security |
||
|
Countries Catered |
|||
|
North America |
·
United
States ·
Canada ·
Mexico |
||
|
Europe |
·
United Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest of Europe |
||
|
Asia Pacific |
·
China ·
India ·
Japan ·
Australia ·
South
Korea ·
Rest
of Asia Pacific |
||
|
Latin America |
·
Brazil ·
Argentina ·
Rest of Latin America |
||
|
Middle East
& Africa
|
·
Saudi
Arabia ·
South
Africa ·
Rest
of MEA |
||
|
Key Companies |
|||
|
·
IBM |
|||
Global Chronic Disease Management Market Dynamics
The Chronic Disease Management
(CDM) marketplace dynamics are formed through a mixture of drivers, tendencies,
opportunities, restraints, and demanding situations that outline its growth
trajectory. A key driving force is the growing international occurrence of
persistent situations consisting of diabetes, cardiovascular disorders, cancer,
and breathing illnesses, fueled by aging populations and lifestyle-associated risk
factors. Governments and healthcare corporations are shifting withinside the
path of preventive and value-based care, supported by reimbursement models that
encourage long-term disease management. Technological advancements,
collectively with telehealth, AI-driven analytics, far-flung affected
individual tracking, and wearable devices, are transforming care delivery,
allowing real-time tracking and personalised treatment plans. Key tendencies
encompass developing adoption of virtual therapeutics, integration of digital
fitness records (EHR) with CDM platforms, and the growth of home-primarily
based totally and digital care services. Opportunities lie in rising markets,
in which the persistent ailment burden is growing along with growing healthcare
investments, in addition to partnerships among healthcare companies, payers,
and generation innovators. However, restraints consisting of excessive prices
of superior CDM solutions, restrained virtual literacy amongst patients, and
worries over record privacy and interoperability hinder adoption. Challenges
continue to be in making sure affected person adherence, integrating numerous
virtual equipment into medical workflows, addressing healthcare disparities
throughout regions, and preserving regulatory compliance. Overall, the CDM
marketplace is evolving rapidly, with virtual transformation and collaborative
care fashions at its core.
Global Chronic Disease
Management Market Segment Analysis
The Chronic Disease Management
(CDM) marketplace is segmented throughout multiple dimensions, reflecting the
variety of situations, technologies, and stakeholders driving its growth. By
disease type, cardiovascular diseases, diabetes, chronic respiratory diseases,
and most cancers dominate because of their excessive occurrence and related
healthcare fees, whilst chronic kidney disorder, neurological disorders,
arthritis & musculoskeletal disorders, intellectual fitness situations, and
different continual situations also contribute substantially to the demand for
established care solutions.
In terms of components, the
marketplace consists of software & solutions, including digital fitness
records (EHR) integration, medical choice assist systems, patient engagement
platforms, remote patient tracking, and analytics gear that beautify care
coordination. Services including consulting & implementation, training
& education, and assist & protection play an essential function in ensuring
powerful deployment and adoption, whilst hardware including faraway tracking
devices, wearable scientific devices, and cellular fitness gear allow real-time
affected person monitoring and control. By mode of delivery, CDM answers are
presented as on-premises systems, cloud-primarily based totally answers, and
web-primarily based totally platforms, with cloud adoption accelerating because
of scalability and cost-effectiveness.
Based on end users, healthcare
vendors remain the most important segment, accompanied via way of means of
payers, patients/individuals, employers imposing company well-being programs,
and studies establishments leveraging CDM insights. By intervention type, the
marketplace covers preventive care control, continual care control,
rehabilitation services, and palliative care, addressing wishes throughout the
care continuum. From a generation perspective, speedy improvements in
telehealth & telemedicine, mHealth applications, synthetic intelligence and
device learning, massive data & analytics, IoT-enabled related devices, and
blockchain for steady fitness records control are reshaping continual care
delivery. Together, those segments illustrate how CDM is evolving into a
holistic environment that leverages virtual innovation, collaborative care
models, and data-driven choice-making to enhance patient outcomes and decrease
healthcare fees worldwide.
Global Chronic Disease
Management Market Regional Analysis
The Chronic Disease Management
(CDM) marketplace indicates various booms throughout regions, prompted by
healthcare infrastructure, disease burden, and generation adoption. North
America leads the marketplace because of the excessive incidence of continual
illnesses, superior healthcare structures, robust compensation frameworks, and
early adoption of virtual fitness technology like telemedicine and remote
monitoring. Europe follows with growing authority’s initiatives, supportive
healthcare policies, and a focal point on value-primarily based totally care
models. The Asia-Pacific vicinity is experiencing the quickest boom, pushed via
way of means of a growing patient population, growing healthcare investments,
fast virtual fitness adoption, and growing awareness approximately preventive
care in countries including China, India, and Japan. In Latin America, the boom
is supported via way of means of enhancing healthcare get admission to and government
programs focused on chronic conditions, though demanding situations continue to
be in affordability and infrastructure. The Middle East & Africa gift
rising opportunities, with sluggish upgrades in healthcare structures and
growing demand for virtual solutions to control chronic diseases.
Global Chronic Disease Management Market Key Players
·
TriZetto Corporation
·
IBM
·
Pegasystems Inc.
·
EXL Healthcare
·
AxisPoint Health
·
Wellcentive, Inc.
·
Medecision, Inc.
·
i2i Systems, Inc.
·
HealthSmart Holdings, Inc.
·
Allscripts Healthcare Solutions, Inc.
·
ZeOmega Inc.
·
Epic Corporation Inc.
Recent Developments
In September 2025, Roche agreed
to buy biotech firm 89bio for up to $3.5 billion in 2025. The acquisition is
aimed at metabolic dysfunction-associated steatohepatitis (MASH), which is tied
to chronic conditions like type 2 diabetes and obesity.
In April 2025, DarioHealth
entered a strategic partnership with a national benefit plan administrator to
offer its cardiometabolic solution, including a GLP-1 support program, to
employers. This has already begun contributing to recurring revenues.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
The global chronic disease management market was valued at USD 6.14 billion in 2024 and is projected to reach USD 15.94 billion by 2033, growing at a CAGR of 14.2% from 2025 to 2033.
